HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $271,000 | -30.0% | 30,584 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $387,000 | -33.2% | 30,584 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $579,000 | -27.4% | 30,584 | +36.8% | 0.00% | -33.3% |
Q4 2021 | $797,000 | -2.7% | 22,361 | 0.0% | 0.00% | -25.0% |
Q3 2021 | $819,000 | +29.0% | 22,361 | +38.2% | 0.00% | +33.3% |
Q2 2021 | $635,000 | +38.9% | 16,179 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $457,000 | -11.8% | 16,179 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $518,000 | +28.9% | 16,179 | +30.1% | 0.00% | 0.0% |
Q3 2020 | $402,000 | -5.9% | 12,434 | -19.7% | 0.00% | -20.0% |
Q2 2020 | $427,000 | +120.1% | 15,480 | +42.4% | 0.01% | +66.7% |
Q1 2020 | $194,000 | -32.6% | 10,867 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $288,000 | +48.5% | 10,867 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $194,000 | +25.2% | 10,867 | +54.4% | 0.00% | 0.0% |
Q2 2019 | $155,000 | -27.9% | 7,038 | 0.0% | 0.00% | -25.0% |
Q1 2019 | $215,000 | +39.6% | 7,038 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $154,000 | – | 7,038 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Karst Peak Capital Ltd | 225,000 | $5,195,000 | 19.07% |
AIA Investment Management Private Ltd | 354,035 | $8,175,000 | 3.37% |
Bellevue Group AG | 440,169 | $10,164,000 | 0.67% |
Prince Street Capital Management LLC | 81,400 | $1,879,000 | 0.46% |
PRUDENTIAL PLC | 4,112,412 | $94,956,000 | 0.38% |
OppenheimerFunds, Inc. | 4,265,943 | $98,501,000 | 0.14% |
Fullerton Fund Management Co Ltd. | 9,941 | $230,000 | 0.13% |
SECTORAL ASSET MANAGEMENT INC | 31,628 | $730,000 | 0.10% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 1,803,955 | $41,653,000 | 0.08% |
Sands Capital Management | 830,520 | $19,177,000 | 0.07% |